Novavax To Launch Clinical Trial Of Ebola Vaccine; Sarepta Announces Update On Eteplirsen
October 28, 2014 at 05:14 AM EDT
Novavax, Inc. will launch a Phase 1 clinical trial of an Ebola vaccine candidate in December.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|